CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

GE to provide attendees with overview of new oncology solutions at ASCO annual meeting

GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.

31 May 2012

Insmed initiates patient screening for ARIKACE phase 2 NTM lung disease trial

Insmed Incorporated, a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2 clinical trial, Treatment with ARIKACE to Realize Greater Efficacy Trial (TARGET-NTM), of ARIKACE (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacterial (NTM) lung disease.

24 May 2012

$Children with pelvic and thigh fractures rarely develop dangerous blood clots$

Children with pelvic and thigh fractures rarely develop dangerous blood clots

Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.

21 May 2012

$Anti-clotting drugs rarely needed in children with big-bone fractures$

Anti-clotting drugs rarely needed in children with big-bone fractures

21 May 2012

Large survey of genetic variation offers insights into human diseases

A large survey of human genetic variation, published today in the online version of the journal Science, shows that rare genetic variants are not so rare after all and offers insights into human diseases.

19 May 2012

More than 55% of U.S. adults lose or break their sunglasses every year

More than 55 percent of adults in the United States lose or break their sunglasses every year, according to a new report by The Vision Council.

18 May 2012

New insight into treatment patterns for people with stage two and three rectal cancer

Research from the University of Alberta provides new insight into treatment patterns for people with stage two and three rectal cancer-information that ultimately will help physicians improve care strategies for patients provincewide.

16 May 2012

Flexpoint obtains purchase order for disposable colonoscope device

Flexpoint Sensor Systems, Inc., a leader in design and supply of thin film sensing technology, announced today that they have received a purchase order for the a disposable colonoscope device.

15 May 2012

NBHA commends FDA for continuing investigation of bisphosphonate treatment for osteoporosis

In response to today's Perspective pieces published in the New England Journal Of Medicine, the National Bone Health Alliance (NBHA), a public-private partnership bringing together the expertise and resources of its 42 members from the private and non-profit sectors to collectively advance bone health and prevent disease, commends the U.S. Food and Drug Administration (FDA) for continuing to investigate the risks and benefits of long-term bisphosphonate treatment.

11 May 2012

Detailing presidential politics, policies and fundraising

In this pair of stories, The Associated Press offers "clarity" on some of the issues in play in the presidential campaign as well as a report from the campaign trail.

11 May 2012

Bioactive formulation for optimal eye health

Morinda Bioactives (formerly Tahitian Noni International) recently announced the release of seven new Fit Body Composition Supplements, one of which is Fit Eye. Fit Eye provides an exclusive formulation of highly effective bioactives derived from the most potent sources, including research-recommended levels of lutein, to support optimal eye health.

8 May 2012

New data from Acucela’s ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

8 May 2012

MAP Pharmaceuticals first quarter net loss increases to $17.8 million

MAP Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2012.

5 May 2012

Affymetrix total revenue decreases to $65.2 million

Affymetrix, Inc., today reported its operating results for the first quarter of 2012. Total revenue for the quarter was $65.2 million, as compared to total revenue of $73.7 million for the same period of 2011.

4 May 2012

Study captures positive experiences of people with bipolar disorder

The problems of living with bipolar have been well documented, but a new study by Lancaster University has captured the views of those who also report highly-valued, positive experiences of living with the condition.

4 May 2012

Accuray launches Prostate Advances in Comparative Evidence Study

Accuray Incorporated, the premier radiation oncology company, announced today the launch of the Prostate Advances in Comparative Evidence (PACE) Study, an international, multi-center, randomized study to compare CyberKnife® Stereotactic Body Radiation Therapy (SBRT), da Vinci assisted and manual laparoscopic surgery and conventionally fractionated intensity modulated radiation therapy (IMRT), for the treatment of localized prostate cancer.

27 Apr 2012

Funders should follow lead of U.S. in creating policies for scientific research oversight

"The controversy over the research into the genetic modification of the H5N1 flu virus, finally approved for publication, should offer a reminder of the importance of debate" over dual-use technology, a Nature editorial states.

27 Apr 2012

Consumer-directed health plans surge, get boost from health law

The concept is also central to Republican-backed market-based reforms. Also in the news, media outlets analyze what's a stake as the Supreme Court considers challenges to the health law, and Health and Human Services Secretary Kathleen Sebelius reiterates the administration's confidence that the law will be upheld.

21 Apr 2012

Chip-scale NIST sensor successfully measures human brain activity

A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.

20 Apr 2012

FDA's three draft guidances on biosimilars - BIO submits comments

The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food and Drug Administration (FDA) on three draft guidance documents on biosimilar products.

18 Apr 2012